Sign in

CIK 0001061983

  • Large accelerated filer

CYTOKINETICS INC

Sign in to watch
Ticker
CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
943291317
Phone
+1 650-624-3000
Business address
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,320,469
in 18 filings, $12.5M under 10b5-1 plans

Net −$13,320,469. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-08 Malik Fady Ibraham EVP Research & Development Sale 10b5-1 −2,500 $38.07 $95K 163,164
2023-05-31 Blum Robert I President & CEO Exercise or conversion 10b5-1 +12,500 $9.65 $121K 453,558
2023-05-31 Blum Robert I President & CEO Sale 10b5-1 −12,500 $37.67 $471K 441,058
2023-05-31 Blum Robert I President & CEO Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 −12,500 58,191
2023-05-16 Blum Robert I President & CEO Exercise or conversion 10b5-1 +12,500 $9.65 $121K 453,558
2023-05-16 Blum Robert I President & CEO Sale 10b5-1 −12,500 $37.41 $468K 441,058
2023-05-16 Blum Robert I President & CEO Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 −12,500 70,691
2023-05-15 HENDERSON JOHN T Director Exercise or conversion 10b5-1 +4,166 $6.78 $28K 29,586
2023-05-15 HENDERSON JOHN T Director Sale 10b5-1 −4,166 $37.77 $157K 25,420
2023-05-15 HENDERSON JOHN T Director Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 −4,166 0
2023-05-11 Malik Fady Ibraham EVP Research & Development Sale 10b5-1 −1,787 $39.50 $71K 165,396
2023-05-10 SMITH SANDFORD D Director Grant or award +5,000 17,831
2023-05-10 SMITH SANDFORD D Director Grant or award · Non-Qualified Stock Option (Right to Buy) +10,000 10,000
2023-05-10 WIERENGA WENDALL Director Grant or award +5,000 17,831
2023-05-10 WIERENGA WENDALL Director Grant or award · Non-Qualified Stock Option (Right to Buy) +10,000 10,000
2023-05-10 Wysenski Nancy Director Grant or award +5,000 16,671
2023-05-10 Wysenski Nancy Director Grant or award · Non-Qualified Stock Option (Right to Buy) +10,000 10,000
2023-05-10 PARSHALL B LYNNE Director Grant or award +5,000 15,000
2023-05-10 PARSHALL B LYNNE Director Grant or award · Non-Qualified Stock Option (Right to Buy) +10,000 10,000
2023-05-10 Kaye Edward M. MD Director Grant or award +5,000 18,347

Page 41 of 45 · 885 trades